Cerus Pre-Tax Profit Margin 2010-2024 | CERS
Cerus Pre-Tax Profit Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
2024-03-31 | $0.19B | $-0.03B | -16.23% |
2023-12-31 | $0.19B | $-0.04B | -19.89% |
2023-09-30 | $0.18B | $-0.05B | -26.63% |
2023-06-30 | $0.18B | $-0.05B | -27.32% |
2023-03-31 | $0.18B | $-0.05B | -24.59% |
2022-12-31 | $0.19B | $-0.04B | -21.81% |
2022-09-30 | $0.19B | $-0.04B | -19.79% |
2022-06-30 | $0.18B | $-0.04B | -22.40% |
2022-03-31 | $0.17B | $-0.05B | -27.75% |
2021-12-31 | $0.16B | $-0.05B | -33.13% |
2021-09-30 | $0.14B | $-0.06B | -40.28% |
2021-06-30 | $0.13B | $-0.06B | -45.80% |
2021-03-31 | $0.12B | $-0.06B | -50.00% |
2020-12-31 | $0.12B | $-0.06B | -51.30% |
2020-09-30 | $0.11B | $-0.06B | -57.94% |
2020-06-30 | $0.10B | $-0.07B | -65.35% |
2020-03-31 | $0.10B | $-0.07B | -71.88% |
2019-12-31 | $0.09B | $-0.07B | -77.42% |
2019-09-30 | $0.09B | $-0.07B | -81.61% |
2019-06-30 | $0.08B | $-0.07B | -80.72% |
2019-03-31 | $0.08B | $-0.06B | -77.50% |
2018-12-31 | $0.08B | $-0.06B | -76.00% |
2018-09-30 | $0.07B | $-0.05B | -71.62% |
2018-06-30 | $0.07B | $-0.05B | -76.47% |
2018-03-31 | $0.06B | $-0.05B | -86.67% |
2017-12-31 | $0.05B | $-0.06B | -111.76% |
2017-09-30 | $0.04B | $-0.06B | -136.36% |
2017-06-30 | $0.04B | $-0.06B | -151.22% |
2017-03-31 | $0.04B | $-0.07B | -169.23% |
2016-12-31 | $0.04B | $-0.06B | -161.54% |
2016-09-30 | $0.04B | $-0.07B | -175.68% |
2016-06-30 | $0.04B | $-0.07B | -188.57% |
2016-03-31 | $0.04B | $-0.07B | -191.43% |
2015-12-31 | $0.04B | $-0.06B | -171.43% |
2015-09-30 | $0.04B | $-0.06B | -180.00% |
2015-06-30 | $0.04B | $-0.06B | -156.76% |
2015-03-31 | $0.04B | $-0.05B | -129.73% |
2014-12-31 | $0.04B | $-0.04B | -105.41% |
2014-09-30 | $0.04B | $-0.03B | -69.44% |
2014-06-30 | $0.04B | $-0.03B | -91.89% |
2014-03-31 | $0.04B | $-0.03B | -86.84% |
2013-12-31 | $0.04B | $-0.04B | -107.50% |
2013-09-30 | $0.04B | $-0.04B | -92.86% |
2013-06-30 | $0.04B | $-0.02B | -56.41% |
2013-03-31 | $0.04B | $-0.02B | -44.74% |
2012-12-31 | $0.04B | $-0.02B | -43.24% |
2012-09-30 | $0.04B | $-0.02B | -61.11% |
2012-06-30 | $0.04B | $-0.02B | -45.95% |
2012-03-31 | $0.04B | $-0.02B | -60.00% |
2011-12-31 | $0.03B | $-0.02B | -51.52% |
2011-09-30 | $0.03B | $-0.01B | -37.93% |
2011-06-30 | $0.03B | $-0.02B | -68.00% |
2011-03-31 | $0.02B | $-0.02B | -70.83% |
2010-12-31 | $0.02B | $-0.02B | -73.91% |
2010-09-30 | $0.02B | $-0.02B | -90.91% |
2010-06-30 | $0.02B | $-0.02B | -100.00% |
2010-03-31 | $0.02B | $-0.02B | -110.00% |
2009-12-31 | $0.02B | $-0.02B | -141.18% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.318B | $0.156B |
Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $178.017B | 23.31 |
Stryker (SYK) | United States | $126.483B | 30.29 |
Boston Scientific (BSX) | United States | $111.661B | 35.56 |
EssilorLuxottica (ESLOY) | France | $99.732B | 0.00 |
Medtronic (MDT) | Ireland | $98.953B | 14.81 |
Lonza Group Ag (LZAGY) | Switzerland | $41.070B | 0.00 |
Haleon (HLN) | United Kingdom | $38.630B | 28.20 |
ResMed (RMD) | United States | $27.824B | 26.12 |
Terumo (TRUMY) | Japan | $24.790B | 35.01 |
Koninklijke Philips (PHG) | Netherlands | $23.594B | 18.73 |
Zimmer Biomet Holdings (ZBH) | United States | $21.927B | 14.01 |
Baxter (BAX) | United States | $16.898B | 12.01 |
Insulet (PODD) | United States | $13.778B | 61.09 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.986B | 0.00 |
Demant (WILYY) | Denmark | $9.175B | 0.00 |
BellRing Brands (BRBR) | United States | $7.709B | 36.26 |
Bio-Rad Laboratories (BIO) | United States | $7.704B | 25.19 |
Lantheus Holdings (LNTH) | United States | $5.515B | 13.74 |
Haemonetics (HAE) | United States | $4.287B | 21.14 |
GN Store Nord (GNNDY) | Denmark | $4.205B | 23.62 |
Perrigo (PRGO) | Ireland | $3.570B | 10.82 |
Prestige Consumer Healthcare (PBH) | United States | $3.360B | 15.99 |
Neogen (NEOG) | United States | $3.295B | 31.69 |
TG Therapeutics (TGTX) | United States | $2.904B | 81.70 |
ICU Medical (ICUI) | United States | $2.875B | 25.37 |
Envista Holdings (NVST) | United States | $2.800B | 11.55 |
Green Thumb Industries (GTBIF) | United States | $2.467B | 48.29 |
Agios Pharmaceuticals (AGIO) | United States | $2.386B | 0.00 |
QuidelOrtho (QDEL) | United States | $2.077B | 11.53 |
LeMaitre Vascular (LMAT) | United States | $1.825B | 53.49 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.761B | 0.00 |
Warby Parker (WRBY) | United States | $1.609B | 0.00 |
InMode (INMD) | Israel | $1.468B | 7.80 |
Verano Holdings (VRNOF) | United States | $1.292B | 0.00 |
AdaptHealth (AHCO) | United States | $1.292B | 9.60 |
AtriCure (ATRC) | United States | $1.068B | 0.00 |
Owens & Minor (OMI) | United States | $1.003B | 8.74 |
National Vision Holdings (EYE) | United States | $0.977B | 31.08 |
BioLife Solutions (BLFS) | United States | $0.923B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.791B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.694B | 14.78 |
Evolus (EOLS) | United States | $0.688B | 0.00 |
PetIQ (PETQ) | United States | $0.672B | 21.73 |
Surmodics (SRDX) | United States | $0.599B | 37.48 |
VAREX IMAGING (VREX) | United States | $0.587B | 13.81 |
ZimVie (ZIMV) | United States | $0.506B | 43.16 |
Valneva SE (VALN) | France | $0.501B | 0.00 |
Canopy Growth (CGC) | Canada | $0.495B | 0.00 |
Quanterix (QTRX) | United States | $0.479B | 0.00 |
Biote (BTMD) | United States | $0.459B | 10.57 |
Jin Medical (ZJYL) | China | $0.438B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.394B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.298B | 9.60 |
Zynex (ZYXI) | United States | $0.283B | 38.78 |
Aurora Cannabis (ACB) | Canada | $0.267B | 0.00 |
MacroGenics (MGNX) | United States | $0.263B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.256B | 25.39 |
Sanara MedTech (SMTI) | United States | $0.238B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.234B | 14.75 |
Omeros (OMER) | United States | $0.225B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.220B | 0.00 |
High Tide (HITI) | Canada | $0.171B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.165B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.154B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.150B | 0.00 |
FitLife Brands (FTLF) | United States | $0.140B | 19.89 |
Veru (VERU) | United States | $0.134B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.130B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.114B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.103B | 0.00 |
Fonar (FONR) | United States | $0.102B | 10.29 |
Brainsway (BWAY) | Israel | $0.099B | 0.00 |
InterCure (INCR) | Israel | $0.097B | 16.31 |
Cellectar Biosciences (CLRB) | United States | $0.089B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.071B | 4.66 |
MariMed (MRMD) | United States | $0.071B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.060B | 0.00 |
Safety Shot (SHOT) | United States | $0.055B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.054B | 0.00 |
Bright Green (BGXX) | United States | $0.050B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.049B | 0.00 |
Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
Apyx Medical (APYX) | United States | $0.046B | 0.00 |
Modular Medical (MODD) | United States | $0.046B | 0.00 |
United-Guardian (UG) | United States | $0.044B | 15.97 |
ImmuCell (ICCC) | United States | $0.033B | 0.00 |
Exagen (XGN) | United States | $0.031B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.022B | 0.00 |
Nephros (NEPH) | United States | $0.022B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.016B | 0.00 |
Agape ATP (ATPC) | $0.015B | 0.00 | |
Flora Growth (FLGC) | United States | $0.013B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
GlucoTrack (GCTK) | United States | $0.009B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.006B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.003B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |